documents: FDA-2003-E-0067-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2003-E-0067-0004 | FDA | FDA-2003-E-0067 | Determination of Regulatory Review Period for Purposes of Patent Extension; ELOXATIN | Notice | General Notice | 2003-12-02T05:00:00Z | 2003 | 12 | 2003-12-02T05:00:00Z | 2025-10-23T19:35:22Z | 03-29928 | 0 | 0 | 0900006480481d4d |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref